Purchase Order N3239823P0357
Award Date
9/30/23
Potential Completion Date
9/30/23
Potential Value
$10K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies,...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has a ceiling value of $80,917.66 and a period of performance through September 26, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a long history of supporting federal agencies such as the NIH, CDC, USDA,...
This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This firm-fixed-price purchase order for $180,480.00 was awarded to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, to provide a MiSeq Silver Support Plan for a MiSeq sequencing asset. The contract was issued by the U.S. Navy Bureau of Medicine and Surgery, a defense agency, and has an ultimate completion date of September 25, 2025. Illumina has been awarded multiple prime federal contracts and subcontracts by agencies such as the National Institutes of...
This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation.
The award was made on a sole source basis to Illumina, as the provider of the proprietary...
This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation.
Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50.
The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...